HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.

Abstract
Cell-free DNA (cfDNA) has pioneered the development of noninvasive prenatal testing and liquid biopsy, its emerging applications include organ transplantation, autoimmune diseases, and many other disorders; size profile of cfDNA is a crucial biological property and is essential for its clinical applications. Therefore, a thorough mastery of the characteristic and potential applications of cfDNA size profile is needed. Methods: Based on the recent researches, we summarized the size profile of cfDNA in pregnant women, tumor patients, transplant recipients and systemic lupus erythematosus (SLE) patients to explore the common features. We also concluded the applications of size profile in pre-analytical phases, analytical phases for novel assays, and preparation of quality control materials (QCMs). Results: The size profile of cfDNA shared common features in different populations, and was distributed as a "ladder" pattern with a dominant peak at ~166 bp. However, cfDNA entailed slightly discrepant characteristics due to specific tissues of origin. The dominant peaks of fetal and maternal cfDNA fragments in pregnant women were at 143 bp and 166 bp, respectively. The plasma cfDNA in tumor patients, transplant recipients, and SLE patients had a peak of around 166 bp. In pre-analytical phases, size profile served as a vital indicator to judge the eligibility of specimens, thus ensuring the successful implementation of assays. More importantly, the size profile had the potential to enrich short fragments, calculate fetal fraction, detect fetal abnormalities, predict tumor progress in analytical phase and to guide the preparation of QCMs. Conclusions: Our finding summarized the characteristics and potential applications of cfDNA size profile, providing clinical researchers with novel assays by the extensive application of cfDNA.
AuthorsJiping Shi, Runling Zhang, Jinming Li, Rui Zhang
JournalTheranostics (Theranostics) Vol. 10 Issue 11 Pg. 4737-4748 ( 2020) ISSN: 1838-7640 [Electronic] Australia
PMID32308746 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© The author(s).
Chemical References
  • Cell-Free Nucleic Acids
  • DNA
Topics
  • Animals
  • Cell-Free Nucleic Acids (blood, genetics)
  • DNA (blood)
  • Female
  • Fetus (metabolism)
  • Fluorescence
  • Humans
  • Lupus Erythematosus, Systemic (blood, diagnosis, genetics)
  • Neoplasms (blood, diagnosis, genetics)
  • Pregnancy
  • Prenatal Diagnosis (methods)
  • Transplant Recipients

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: